Northwestern University

Mon 4:00 PM

"Getting a Handle on Neuropharmacology by Targeting Receptor-Associated Proteins"

When: Monday, May 21, 2018
4:00 PM - 5:00 PM  

Where: Ward Building, 5-230, 303 E. Chicago Avenue, Chicago, IL 60611 map it

Audience: Faculty/Staff - Student - Post Docs/Docs - Graduate Students

Contact: Liz Barrera Murphy   312.503.4892

Group: Department of Pharmacology Seminars

Category: Lectures & Meetings


The Department of Pharmacology welcomes David S. Bredt, M.D., Ph.D., Global Head Neuroscience Discovery and Site Head, La Jolla Janssen Pharmaceutical Companies of Johnson & Johnson

Below is a description of the seminar as told by Dr. Bredt:

Targeted therapy for neuropsychiatric disorders requires selective modulation of dysfunctional neuronal pathways. Receptors relevant to CNS disorders typically have associated proteins discretely expressed in specific neuronal pathways; these accessory proteins provide a new dimension for drug discovery. Recent studies show that targeting a TARP auxiliary subunit of AMPA receptors selectively modulates neuronal excitability in specific forebrain pathways relevant to epilepsy. Other medicinally important ion channels, gated by glutamate, g-aminobutyric acid (GABA), and acetylcholine, also have associated proteins, which may be druggable. This emerging pharmacology of receptor-associated proteins provides a new approach for improving drug efficacy while mitigating side effects.

Add Event to Calendar

Add Event To My Group:

Please sign-in